NYSE:ABC

AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Retrieved on: 
Tuesday, August 15, 2023
Veterinary, Pharmaceutical, Finance, General Health, Health, Banking, Professional Services, Health Insurance, Berkshire Hathaway, Yale University, Human resources, University, AmerisourceBergen, JPMorgan Chase, Bayer, Economics, RWTH Aachen University, University of Cologne, Retirement, Acquisition, Alleghany Corporation, ABC, Harvard Business School, Development, NYSE, Management

AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023.

Key Points: 
  • AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023.
  • With the election of Mr. Baumann and Ms. Tyler, the Board of Directors will increase from ten to twelve members, ten of whom are independent.
  • “We look forward to welcoming Mr. Baumann and Ms. Tyler to AmerisourceBergen’s Board of Directors.
  • Ms. Tyler was a director at Alleghany Corporation from January 2019 until its acquisition by Berkshire Hathaway in October 2022.

AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase

Retrieved on: 
Thursday, August 3, 2023
General Health, Finance, Banking, Health, Professional Services, Share repurchase, Telephone, EDGAR, Sale, Goldman Sachs, Prospectus, S-3, Form, NYSE, Security (finance)

The Company is not issuing or selling any shares of its common stock in the offering, is not a party to the variable forward transactions and will not receive any proceeds from sales of the underwritten shares.

Key Points: 
  • The Company is not issuing or selling any shares of its common stock in the offering, is not a party to the variable forward transactions and will not receive any proceeds from sales of the underwritten shares.
  • The concurrent share repurchase will be made under the Company’s share repurchase program and the repurchased shares will be held in treasury.
  • The closing of the concurrent share repurchase will be conditioned upon the closing of the offering and therefore there can be no assurance that the concurrent share repurchase will be completed.
  • The offering is not conditioned upon the completion of the concurrent share repurchase.

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

Retrieved on: 
Wednesday, August 2, 2023
Oncology, Professional Services, Health, Finance, General Health, Pharmaceutical, Banking, Civic, American Association of People with Disabilities, Table, Diabetes, AmerisourceBergen, Telephone, COVID-19, Weight loss, GAAP, Interest expense, Pharmacy, Earnings per share, Carbon, TPG, Delaware Valley, Good Neighbor Pharmacy, Acquisition, Disability, Webcast, Growth, Conference, Bank, Health insurance, Video game, Pharmaceutical industry, Renewable energy, Security (finance), Risk management, Cryptocurrency, Music

Operating income as a percentage of revenue was 1.00 percent in the third quarter of fiscal 2023, an increase of 19 basis points when compared to the prior year quarter.

Key Points: 
  • Operating income as a percentage of revenue was 1.00 percent in the third quarter of fiscal 2023, an increase of 19 basis points when compared to the prior year quarter.
  • Diluted Earnings Per Share: Diluted earnings per share was $2.35 in the third quarter of fiscal 2023, a 22.4 percent increase compared to $1.92 in the previous fiscal year’s third quarter.
  • Diluted Shares Outstanding: Diluted weighted average shares outstanding for the third quarter of fiscal 2023 were 204.4 million, a decrease of 7.4 million shares, or 3.5 percent, versus the prior fiscal year third quarter primarily as a result of share repurchases.
  • Adjusted Diluted Earnings Per Share: Adjusted diluted earnings per share was $2.92 in the third quarter of fiscal 2023, an 11.5 percent increase compared to $2.62 in the previous fiscal year’s third quarter.

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release

Retrieved on: 
Thursday, June 29, 2023
Professional Services, Health, Finance, General Health, Banking, Pharmaceutical, Telephone, Webcast, AmerisourceBergen, NYSE, ABC, Fiscal, Broadcasting

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange.

Key Points: 
  • AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange.
  • Participating in the conference call will be:
    The live call will be webcast via the Company’s website at investor.amerisourcebergen.com .
  • Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
  • Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts and for replay information.

TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology

Retrieved on: 
Friday, June 9, 2023
Finance, Professional Services, Biotechnology, Other Health, Managed Care, Health, Pharmaceutical, Asset Management, Oncology, AmerisourceBergen, Partnership, Acquisition, Physician, NYSE, ABC, Cryptocurrency, Nursing, TPG

TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.

Key Points: 
  • TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.
  • TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company.
  • OneOncology’s affiliated practices, physicians, and management team have also retained a minority interest in the company.
  • The partnership provides OneOncology with additional resources to grow its platform and invest behind clinical, operational, and technical capabilities to continue to deliver high-quality, comprehensive patient care.

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance

Retrieved on: 
Friday, May 12, 2023
General Health, Finance, Health, Professional Services, Pharmaceutical, AmerisourceBergen, Treasury, Walgreens Boots Alliance, Share repurchase, NYSE, ABC, Security (finance), Car rental, Cryptocurrency

AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.

Key Points: 
  • AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.
  • AmerisourceBergen intends to repurchase shares from Walgreens Boots Alliance at the per share price equal to the price in the Rule 144 transaction.
  • The concurrent share repurchase will be made under AmerisourceBergen’s share repurchase program and the repurchased shares will be held in treasury.

AmerisourceBergen Reports Fiscal 2023 Second Quarter Results

Retrieved on: 
Tuesday, May 2, 2023
Professional Services, Health, Finance, General Health, Banking, Pharmaceutical, Gene, Table, AmerisourceBergen, Telephone, COVID-19, GAAP, Interest expense, COVID, Earnings per share, TPG, Earthquake, Cell, Webcast, Depreciation, Growth, Bank, Conference, Video game, Health care, Pharmaceutical industry, Security (finance), Health insurance, Risk management, Airline, Cryptocurrency

Diluted Earnings Per Share: Diluted earnings per share was $2.13 in the second quarter of fiscal 2023, a 17.8 percent decrease compared to $2.59 in the previous fiscal year’s second quarter.

Key Points: 
  • Diluted Earnings Per Share: Diluted earnings per share was $2.13 in the second quarter of fiscal 2023, a 17.8 percent decrease compared to $2.59 in the previous fiscal year’s second quarter.
  • Diluted Shares Outstanding: Diluted weighted average shares outstanding for the second quarter of fiscal 2023 were 204.3 million, a decrease of 7.7 million shares, or 3.6 percent versus the prior fiscal year second quarter primarily as a result of share repurchases.
  • Adjusted Diluted Earnings Per Share: Adjusted diluted earnings per share was $3.50 in the second quarter of fiscal 2023, an 8.7 percent increase compared to $3.22 in the previous fiscal year’s second quarter.
  • Revenue in International Healthcare Solutions was $6.8 billion in the second quarter of fiscal 2023, a decrease of 0.2 percent from the previous fiscal year’s second quarter.

AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub

Retrieved on: 
Tuesday, April 25, 2023
Software, Research, Professional Services, Pharmaceutical, Data Management, Technology, Genetics, Data Analytics, Clinical Trials, Science, Biotechnology, Stem Cells, Health, CGT, Gene, Case management (US healthcare system), Clinical trial, Patient, Physician, Cell, CRM, Ecosystem, Caregiver, Pharmaceutical industry, AmerisourceBergen

AmerisourceBergen , a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey.

Key Points: 
  • AmerisourceBergen , a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey.
  • “Cell and gene therapies offer tremendous promise but the unique characteristics of these treatments – coupled with the urgency with which they need to be delivered – requires flawless execution and heightened coordination from the moment a patient is identified all the way through the treatment administration,” said Dale Hanna, Director of Cell & Gene Therapy Solutions at AmerisourceBergen.
  • With the CGT Integration Hub, AmerisourceBergen can complete platform integrations with various supply chain partners, including therapy developers and CGT software providers.
  • But the healthcare system needs to keep pace with the science,” said Lung-I Cheng, Vice President of Cell & Gene Therapy at AmerisourceBergen.

TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic

Retrieved on: 
Thursday, April 20, 2023
Biotechnology, Pharmaceutical, Managed Care, Finance, Oncology, Health, Professional Services, Other Health, Martha Plimpton, Exercise, Centerview Partners, Kidney disease, Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, Partnership, AmerisourceBergen, Chronic kidney disease, TPG Inc., Clinical trial, Morgan, Lewis & Bockius, Tax, P.C, Kelsey-Seybold Clinic, Research, Sidley Austin, EBITDA, Acquisition, Home, Patient, Physician, Practice management, ABC, Depreciation, Growth, EPS, General Atlantic, Paul, Weiss, Rifkind, Wharton & Garrison, Guggenheim Partners, NYSE, Data Analytics Library, Nursing, Management, Bookkeeping, TPG

TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced that they have agreed to acquire OneOncology, a network of leading oncology practices, from General Atlantic, a leading global growth equity firm.

Key Points: 
  • TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced that they have agreed to acquire OneOncology, a network of leading oncology practices, from General Atlantic, a leading global growth equity firm.
  • TPG has agreed to acquire a majority interest in OneOncology, and AmerisourceBergen will acquire a minority interest in the company.
  • TPG, AmerisourceBergen, and OneOncology’s affiliated practices, physicians, and management team will form a new joint venture that will acquire OneOncology from its existing shareholders, including current majority owner General Atlantic.
  • Centerview Partners is serving as exclusive financial advisor to OneOncology and General Atlantic, and Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as OneOncology and General Atlantic’s legal advisor.

AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release

Retrieved on: 
Wednesday, March 29, 2023
General Health, Pharmaceutical, Health, Telephone, Webcast, AmerisourceBergen, NYSE, ABC, Fiscal, Broadcasting

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange.

Key Points: 
  • AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange.
  • Participating in the conference call will be:
    The live call will be webcast via the Company’s website at investor.amerisourcebergen.com .
  • Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
  • Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts and for replay information.